Table 1 Clinical and laboratory characteristics
Parameters | Total(N = 673) |
|---|---|
Age (years) | 59.1 ± 10.8 |
Male sex [n (%)] | 543(80.7) |
Smoking [n (%)] | 315(46.8) |
Alcohol intake[n (%)] | 251(37.3) |
Hypertension [n (%)] | 323(48.0) |
Family history of CAD [n (%)] | 145(21.5) |
Hypercholesterolemia [n (%)] | 287(42.6) |
Diabetes [n (%)] | 170(25.3) |
LVEF (%) | 61 ± 7 |
Regular drug taking[n (%)] | 594(88.3) |
Pre-procedural laboratory parameters | |
 SBP (mmHg) | 134 ± 26 |
 HR (bpm) | 75 ± 10 |
 WBC (× 109/L) | 7.49 ± 2.33 |
 Monocyte (× 109/L) | 0.52 ± 0.22 |
 TG(mmol/l) | 1.61(1.18–2.48) |
 TC(mmol/l) | 4.04 ± 1.21 |
 LDL-C(mmol/l) | 1.32(1.06–2.22) |
 HDL-C(mmol/l) | 1.48(0.93–2.48) |
 Gensini score | 36(20–64) |
 MHR | 0.40 ± 0.30 |
MHR quartiles | |
 Q1(≤0.19) | 167(24.8) |
 Q2(0.19–0.33) | 177(26.3) |
 Q3(0.33–0.53) | 158(23.5) |
 Q4(> 0.53) | 171(25.4) |
 Follow-up time (months) | 39 ± 25 |